1,707
Participants
Start Date
October 1, 2010
Primary Completion Date
January 25, 2011
Study Completion Date
June 24, 2011
Quadrivalent seasonal influenza vaccine GSK2282512A
Single intramuscular dose
FluLavalTM-VB
Single intramuscular dose
FluLavalTM-YB
Single intramuscular dose
GSK Investigational Site, Durango
GSK Investigational Site, Endwell
GSK Investigational Site, Jefferson Hills
GSK Investigational Site, Elkridge
GSK Investigational Site, Estado de México
GSK Investigational Site, Wichita
GSK Investigational Site, Mesa
GSK Investigational Site, Wenatchee
GSK Investigational Site, Coquitlam
GSK Investigational Site, Surrey
GSK Investigational Site, Québec
GSK Investigational Site, Cuernavaca
Lead Sponsor
GlaxoSmithKline
INDUSTRY